Of these 4 deaths, 0 were in group A and 4 were in group B. The “near-miss” morbidity was higher than the mortality (total 20/124; 6/60 in Group-A and 14/64 in Group-B). The delayed referrals and the lack of an active 3rd stage management in Group-B were responsible for most of the adverse events.